Cargando…

Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension

Morning blood pressure (BP) surge is reported as a risk factor for cardiovascular events and end-organ damage independent of the 24-h BP level. Controlling morning BP surge is therefore important to help prevent onset of cardiovascular disease. We compared the efficacy of azilsartan and candesartan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rakugi, Hiromi, Kario, Kazuomi, Enya, Kazuaki, Sugiura, Kenkichi, Ikeda, Yoshinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011626/ https://www.ncbi.nlm.nih.gov/pubmed/24710336 http://dx.doi.org/10.1097/MBP.0000000000000042

Ejemplares similares

Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I–II essential hypertension: a randomized, double-blind clinical study
por: Rakugi, Hiromi, et al.
Publicado: (2012)

Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
por: Ito, Shuichi, et al.
Publicado: (2021)

Correction to: Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
por: Ito, Shuichi, et al.
Publicado: (2022)

Clinical Implications of the Change in Glomerular Filtration Rate with Adrenergic Blockers in Patients with Morning Hypertension: The Japan Morning Surge-1 Study
por: Shibasaki, Seiichi, et al.
Publicado: (2013)

Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study
por: Rakugi, Hiromi, et al.
Publicado: (2022)

Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertension
por: Weber, Michael A., et al.
Publicado: (2014)

Different age‐related impacts of lean and obesity on cardiovascular prognosis in Japanese patients with cardiovascular risks: The J‐HOP (Japan Morning Surge‐Home Blood Pressure) Study
por: Toriumi, Shinichi, et al.
Publicado: (2021)

Atrial fibrillation is associated with cardiovascular events in obese Japanese with one or more cardiovascular risk factors: The Japan Morning Surge Home Blood Pressure (J‐HOP) Study
por: Watanabe, Hiroaki, et al.
Publicado: (2021)

Association of lower nighttime diastolic blood pressure and hypoxia with silent myocardial injury: The Japan Morning Surge‐Home Blood Pressure study
por: Kubota, Kana, et al.
Publicado: (2020)

Twenty‐Four‐Hour Blood Pressure‐Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double‐Blind Multicenter Study
por: Kario, Kazuomi, et al.
Publicado: (2023)

Morning Blood Pressure Surge as a Predictor of Outcome in Patients with Essential Hypertension
por: Abdel-Khalik, Mohamed Y., et al.
Publicado: (2017)

Rationale, study design, and implementation of the ACS1 study: effect of azilsartan on circadian and sleep blood pressure as compared with amlodipine
por: Kario, Kazuomi, et al.
Publicado: (2014)

Self‐measured worksite blood pressure and its association with organ damage in working adults: Japan Morning Surge Home Blood Pressure (J‐HOP) worksite study
por: Tomitani, Naoko, et al.
Publicado: (2020)

Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension
por: Kario, Kazuomi, et al.
Publicado: (2013)

Seasonal Variation of Home Blood Pressure and Its Association With Target Organ Damage: The J-HOP Study (Japan Morning Surge-Home Blood Pressure)
por: Narita, Keisuke, et al.
Publicado: (2020)

The Combination of Non-dipper Heart Rate and High Brain Natriuretic Peptide Predicts Cardiovascular Events: The Japan Morning Surge-Home Blood Pressure (J-HOP) Study
por: Ogoyama, Yukako, et al.
Publicado: (2020)

Automatically assessed P‐wave predicts cardiac events independently of left atrial enlargement in patients with cardiovascular risks: The Japan Morning Surge‐Home Blood Pressure Study
por: Yokota, Ayako, et al.
Publicado: (2020)

Efficacy of azilsartan on left ventricular diastolic dysfunction compared with candesartan: J-TASTE randomized controlled trial
por: Ito, Shin, et al.
Publicado: (2023)

Key Points of the 2019 Japanese Society of Hypertension Guidelines for the Management of Hypertension
por: Kario, Kazuomi
Publicado: (2019)

A New Baroreceptor Sensitivity-Restoring Ca-Channel Blocker Diminishes Age-Related Morning Blood Pressure Increase in Hypertensive Patients: Open-Label Monitoring of Azelnidipine Treatment for Hypertension in the Early Morning (At-HOME) Study
por: Kario, Kazuomi, et al.
Publicado: (2010)

Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study
por: Enya, Kazuaki, et al.
Publicado: (2018)

Association of Morning Hypertension Subtype With Vascular Target Organ Damage and Central Hemodynamics
por: Oh, Jaewon, et al.
Publicado: (2017)

Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A Post Hoc Analysis of the ESAX-HTN Study
por: Kario, Kazuomi, et al.
Publicado: (2020)

Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
por: Juhasz, Attila, et al.
Publicado: (2018)

Azilsartan: Current Evidence and Perspectives in Management of Hypertension
por: Pradhan, Akshyaya, et al.
Publicado: (2019)

Efficacy and Safety of Azilsartan and Telmisartan in Hypertensive Patients
por: Kumar, Alok, et al.
Publicado: (2021)

Persistent olmesartan-based blood pressure–lowering effects on morning hypertension in Asians: the HONEST study
por: Kario, Kazuomi, et al.
Publicado: (2016)

COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19
por: Shibata, Shigeru, et al.
Publicado: (2022)

Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19
por: Matsumoto, Chisa, et al.
Publicado: (2022)

Cost-effectiveness of digital therapeutics for essential hypertension
por: Nomura, Akihiro, et al.
Publicado: (2022)

Azilsartan Improves Salt Sensitivity by Modulating the Proximal Tubular Na(+)-H(+) Exchanger-3 in Mice
por: Hatanaka, Masaki, et al.
Publicado: (2016)

Cost Effectiveness Analysis of Candesartan Therapy in Comparison to Candesartan-Amlodipine Therapy on Hypertensive Outpatients
por: Baroroh, Faridah, et al.
Publicado: (2019)

Prognostic Utility of Morning Blood Pressure Surge for 20‐Year All‐Cause and Cardiovascular Mortalities: Results of a Community‐Based Study
por: Cheng, Hao‐Min, et al.
Publicado: (2017)

Chronotherapy for morning blood pressure surge in hypertensive patients: a systematic review and meta-analysis
por: Xie, Ziyan, et al.
Publicado: (2021)

A Prospective Study of Azilsartan Medoxomil in the Treatment of Patients with Essential Hypertension and Type 2 Diabetes in Asia
por: Deerochanawong, Chaicharn, et al.
Publicado: (2022)

Effect of esaxerenone on nocturnal blood pressure and natriuretic peptide in different dipping phenotypes
por: Kario, Kazuomi, et al.
Publicado: (2021)

Clinical utility of azilsartan–chlorthalidone fixed combination in the management of hypertension
por: Shuster, Jerrica E, et al.
Publicado: (2012)

Differences in ambulatory blood pressure profiles between Japanese and Thai patients with hypertension /suspected hypertension
por: Tomitani, Naoko, et al.
Publicado: (2020)

Age is an Independent Risk Factor for the Early Morning Blood Pressure Surge in Patients Never-Treated for Hypertension
por: Lee, Dong-Hyeon, et al.
Publicado: (2009)

Relationship between mean platelet volume and morning blood pressure surge in newly diagnosed hypertensive patients
por: Uçar, Hakan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f52m9tku4k3tos58piaomj7spv